M. Han, G. Criner, M. Dransfield, D. Halpin, C. E. Jones, S. Kilbride, P. Lange, David A. Lipson, D. Lomas, F. Martinez, I. Naya, S. Pascoe, R. Wise, D. Singh
{"title":"单吸入三联疗法预防慢性阻塞性肺病临床重要恶化(CID): IMPACT试验的前瞻性分析","authors":"M. Han, G. Criner, M. Dransfield, D. Halpin, C. E. Jones, S. Kilbride, P. Lange, David A. Lipson, D. Lomas, F. Martinez, I. Naya, S. Pascoe, R. Wise, D. Singh","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2438","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":371205,"journal":{"name":"A102. COPD: THERAPY","volume":"59 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Preventing Clinically Important Deterioration (CID) of COPD with Single-inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol: A Prospective Analysis of the IMPACT Trial\",\"authors\":\"M. Han, G. Criner, M. Dransfield, D. Halpin, C. E. Jones, S. Kilbride, P. Lange, David A. Lipson, D. Lomas, F. Martinez, I. Naya, S. Pascoe, R. Wise, D. Singh\",\"doi\":\"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2438\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":371205,\"journal\":{\"name\":\"A102. COPD: THERAPY\",\"volume\":\"59 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"A102. COPD: THERAPY\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2438\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"A102. COPD: THERAPY","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2438","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Preventing Clinically Important Deterioration (CID) of COPD with Single-inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol: A Prospective Analysis of the IMPACT Trial